First, they found that although primary aldosteronism patients (with adrenal adenoma or bilateral adrenal hyperplasia) were more insulin resistant than age-, sex- and BMI–matched normal controls, the severity of the insulin resistance was less evident than in patients with EH. The gene discussed is INS; the disease is congenital adrenal hyperplasia.